医护一体化在人工肝治疗肝衰竭患者中的应用  

The role of health care integration in the prevention of adverse reactions of artificial liver

作　　者：宋甜爽 陈珍[1] 李自琼[1] 周永碧[1] 黄文祥[1] 

机构地区：[1]重庆医科大学附属第一医院感染科,重庆400016

出　　处：《西部医学》2017年第1期123-126,130,共5页Medical Journal of West China

基　　金：国家临床重点专科护理建设项目[(2010)305]

摘　　要：目的探讨医护一体化模式在人工肝支持系统(ALSS)(简称人工肝)治疗肝衰竭患者中的应用及效果评价。方法将100例肝衰竭采用人工肝治疗患者分为观察组和对照组各50例,观察组实施医护一体化管理模式,对照组给予传统护理服务模式。实施12个月(2015年2月~2016年2月)后比较两组患者人工肝治疗过程中不良反应的发生率、患者满意度以及生活质量。结果实施医护一体化管理模式后,观察组患者人工肝治疗过程中不良反应的发生率有所降低(P<0.05),患者满意度明显提高(P<0.01),生活质量评分显著优于对照组(P<0.05)。结论应用医护一体化模式可以降低肝衰竭患者人工肝治疗过程中不良反应的发生率,并可提高患者的生活质量和满意度,可在临床推广应用。Objective To study the application and effect evaluation of health care integration model in artificial liver support system （ALSS） in the treatment of patients with liver failure. Methods 100 cases of liver failure were divided into observation group and control group. 50 cases in the observation group were treated with the integrated management model. 50 cases in the control group were given the traditional nursing service mode. After 12 months （February 2015 to February 2016）, the incidence of adverse reactions, patient satisfaction and quality of life were compared between the two groups. Results After the implementation of health integrated management model, the adverse reaction in the group treated with artificial liver process occurring rate decreased （P〈0.05）. The satisfaction degree of the patients increased obviously （P〈0.01）. The quality of life score was significantly better than that of the control group （P〈0. 05）. Conclusion Application of health care integration model can reduce the incidence of adverse reactions in liver failure patients undergoing artificial liver treatment and improve the quality of life and patient satisfaction.

关 键 词：医护一体化 肝衰竭 人工肝 不良反应 生活质量 

分 类 号：R575.3[医药卫生—消化系统]